INNA-051 is a COVID-19 vaccine candidate developed by Ena Respiratory. It is an investigational small-molecule Toll-like receptor 2/6 (TLR2 / TLR6) agonist administered as a nasal spray.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.